Itemaren erregistro erraza erakusten du

dc.contributor.authorHerrero, Jesús-Miguel
dc.contributor.authorVega, Pablo
dc.contributor.authorSalve, María
dc.contributor.authorBujanda Fernández de Pierola, Luis ORCID
dc.contributor.authorCubiella, Joaquín
dc.date.accessioned2018-12-13T13:01:35Z
dc.date.available2018-12-13T13:01:35Z
dc.date.issued2018-10-25
dc.identifier.citationBMC Gastroenterology 18 : (2018) // Article ID 155es_ES
dc.identifier.issn1471-230X
dc.identifier.urihttp://hdl.handle.net/10810/30330
dc.description.abstractBackgroundSymptom based referral criteria for colorectal cancer (CRC) detection are the cornerstone of the strategy to improve prognosis in CRC. In 2017, the National Institute for Health and Care Excellence (NICE) updated their referral criteria (2017 NG12). Recently, several studies have evaluated the faecal haemoglobin (f-Hb) concentration in this setting. The aim of this study is to evaluate the diagnostic accuracy of the 2017 NG12 referral criteria and to compare them with the CG27 referral criteria, the f-Hb concentration and two f-Hb based prediction model: COLONPREDICT and FAST Score.MethodsThis is a post-hoc diagnostic test study performed within the COLONPREDICT study database (1572 patients, CRC prevalence 13.6%). We assessed symptoms, the 2017 NG12 and CG27 referral criteria and determined the f-Hb before performing a colonoscopy. We compared the discriminatory ability using the area under the curve (AUC) and the sensitivity and specificity at pre-stablished thresholds with the McNemar's test.ResultsThe 2017 NG12 referral criteria discriminatory ability (AUC 0.53; 95% confidence interval- CI 0.49-0.57) was inferior to the CG27 version (AUC 0.59; 95% CI 0.55-0.63; p=0.01), the f-Hb concentration (AUC 0.86; 95% CI 0.84-0-89; p<0.001), the COLONPREDICT Score (AUC 0.92; 95% CI 0.91-0.94; p<0.001) or the FAST Score (AUC 0.87; 95% CI 0.85-0.89; p<0.001). The number of patients meeting each criteria were as follows: 2017 NG12 and CG27=94.1% and 52.2%; f-Hb 20 and10g/g faeces=38.6 and 44.3%; COLONPREDICT Score5.6 and3.2=29.4 and 63.2% and FAST Score4.50 and2.12=37.1 and 87.0%. The 2017 NG12 criteria were more sensitive (100%) than the CG27 criteria (68.2%), the f-Hb (20g/g) (91.2%), the f-Hb (10g/g) (93.5%), the COLONPREDICT Score (5.6) (90.1%) and the FAST Score (4.50) (89.8%) (p0.001) and equivalent to the COLONPREDICT Score (3.5) (99.5%) or the FAST Score (2.12) (100.0%) (p=1). However, their specificity (6.8%) was significantly lower than any of the evaluated criteria (50.3%, 69.6%, 63.4%, 78.7%, 45.8%, 71.3%, 13.9%; p<0.001).ConclusionReferral criteria based on f-Hb measurement, either as a single test or within prediction models, are more accurate than symptom-based referral criteria for CRC detection in symptomatic patients.es_ES
dc.description.sponsorshipThis study was supported by a grant from Instituto de Salud Carlos III, Madrid, Spain (PI11/00094). Instituto de Salud Carlos III had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. JC has received an intensification grant through the European Commission funded "BIOCAPS" project (FP-7-REGPOT 2012-2013-1, Grant agreement no. FP7-316265).es_ES
dc.language.isoenges_ES
dc.publisherBiomed Centrales_ES
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/316265es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectcolorectal canceres_ES
dc.subjectfaecal immunochemical testes_ES
dc.subjectdiagnostic accuracyes_ES
dc.subjectrisk stratificationes_ES
dc.subjecthemoglobin concentrationes_ES
dc.subjectindicatorses_ES
dc.subjectaccuracyes_ES
dc.subjectdiseasees_ES
dc.subjectsystemes_ES
dc.titleSymptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThe Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-018-0887-7es_ES
dc.identifier.doi10.1186/s12876-018-0887-7
dc.departamentoesMedicinaes_ES
dc.departamentoeuMedikuntzaes_ES


Item honetako fitxategiak

Thumbnail
Thumbnail

Item hau honako bilduma honetan/hauetan agertzen da

Itemaren erregistro erraza erakusten du

The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Bestelakorik adierazi ezean, itemaren baimena horrela deskribatzen da:The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.